Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Sun Pharma agrees to supply at MFN pricing to U.S. medicaid programmes

The U.S. is the company’s largest market for innovative medicines and a cornerstone of its long-term growth strategy, generating approximately 27% of the company’s global revenue.

Sun Pharma agrees to supply at MFN pricing to U.S. medicaid programmes

We haven't written up this one. The Hindu - Sci-Tech has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at thehindu.com →

More in Health & Medicine

More from Wednesday 2 September →